Kudos, a platform dedicated to showcasing research, has announced a new partnership with Johnson & Johnson Innovative Medicine (J&J). This collaboration aims to amplify the reach and educational impact of J&J's clinical trial publications and other outputs.
Kudos will create dedicated Clinical Story pages, which are microsites featuring plain language summaries of clinical trials. These summaries will be linked to peer-reviewed journal articles and other educational materials. These Stories will be organized into Showcases for specific diseases or therapy areas, enhancing the accessibility and understanding of J&J's clinical research.
Initially, J&J’s microsites on Kudos will target audiences in the United States, with plans to expand globally. Kudos will offer comprehensive metrics on discoverability and readership, providing J&J with valuable insights into the profile of readers and the channels they utilize.
Kudos is known for providing a trusted environment for showcasing research content. It has a registration base of half a million top researchers worldwide and an established client base that includes leading publishers and universities. The partnership with J&J marks Kudos’ expanding collaboration with life science companies.
Click here to read the original press release.
